Trials / Completed
CompletedNCT00991653
Weight Fluctuation After Breast Cancer Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- The Royal Bournemouth Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to identify and quantify the factors associated with excess weight gain following treatment for breast cancer. It is believed that breast cancer patients gain more than 4% of their weight at diagnosis which is likely accompanied by an increase in body fat and waist circumference. It is further thought that this excess weight and increase in body fat and waist circumference are associated to tumour characteristics, chemotherapy, menopause status at diagnosis and the presence of genes related to obesity. It is also thought that women treated with chemotherapy have higher levels of glucose and insulin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Fasting blood sample. | Fasting blood sample taken following informed consent for genotyping, glucose and insulin levels. |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2013-01-01
- First posted
- 2009-10-08
- Last updated
- 2018-09-07
Source: ClinicalTrials.gov record NCT00991653. Inclusion in this directory is not an endorsement.